KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Amortization of Deferred Charges (2017 - 2025)

Cardlytics (CDLX) has disclosed Amortization of Deferred Charges for 9 consecutive years, with $328000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 17.59% year-over-year to $328000.0, compared with a TTM value of $1.5 million through Dec 2025, down 6.8%, and an annual FY2025 reading of $1.5 million, down 6.8% over the prior year.
  • Amortization of Deferred Charges was $328000.0 for Q4 2025 at Cardlytics, down from $390000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $3.3 million in Q4 2021 and bottomed at -$731000.0 in Q3 2021.
  • Average Amortization of Deferred Charges over 5 years is $426500.0, with a median of $402500.0 recorded in 2022.
  • Peak annual rise in Amortization of Deferred Charges hit 121.73% in 2021, while the deepest fall reached 169.13% in 2021.
  • Year by year, Amortization of Deferred Charges stood at $3.3 million in 2021, then crashed by 87.83% to $403000.0 in 2022, then rose by 2.73% to $414000.0 in 2023, then decreased by 3.86% to $398000.0 in 2024, then fell by 17.59% to $328000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for CDLX at $328000.0 in Q4 2025, $390000.0 in Q3 2025, and $399000.0 in Q2 2025.